Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)
Guidance for Industry and Food and Drug Administration Staff
FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.
FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19 for the duration of the COVID-19 public health emergency.
TELL US ABOUT YOUR NEXT DESIGN PROJECT
Do you have a question about our services, pricing, samples, resources, or anything else?
Cybersecurity Experts Hail New IoT law | Voler Systems
Cybersecurity experts are keenly aware of ongoing security issues that come with...